Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer

The nonoxidative pentose phosphate pathway allows glucose conversion to ribose for DNA or RNA synthesis and glucose degradation to lactate controlled by transketolase enzyme reactions. It has been postulated, that this pathway is of the utmost importance in tumors for the proliferation process. We d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncology reports 2006-10, Vol.16 (4), p.657-661
Hauptverfasser: STAIGER, Wilko I, COY, Johannes F, GROBHOLZ, Rainer, HOFHEINZ, Ralf-Dieter, LUKAN, Nadine, POST, Stefan, SCHWARZBACH, Matthias H, WILLEKE, Frank
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 661
container_issue 4
container_start_page 657
container_title Oncology reports
container_volume 16
creator STAIGER, Wilko I
COY, Johannes F
GROBHOLZ, Rainer
HOFHEINZ, Ralf-Dieter
LUKAN, Nadine
POST, Stefan
SCHWARZBACH, Matthias H
WILLEKE, Frank
description The nonoxidative pentose phosphate pathway allows glucose conversion to ribose for DNA or RNA synthesis and glucose degradation to lactate controlled by transketolase enzyme reactions. It has been postulated, that this pathway is of the utmost importance in tumors for the proliferation process. We detected a strong upregulation of the mutated transketolase transcript (TKTL1) in a considerable number of patients with gastric cancer (GC) or cancer of the gastroesophageal junction (GEJ). While only 10.8% of the cancer tissues revealed a significant mRNA upregulation, 36.9% of the cancer tissues demonstrated a protein overexpression. We propose that TKTL1 upregulation is a common phenomenon in GC and cancer of the GEJ leading to an enhanced, oxygen-independent glucose usage which might contribute to a more aggressive tumor growth. Since molecular targeted inhibition of transketolase enzyme reactions suppresses tumor growth and metastasis, TKTL1 could be a relevant target for anti-transketolase therapies in gastric cancer.
doi_str_mv 10.3892/or.16.4.657
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68863301</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68863301</sourcerecordid><originalsourceid>FETCH-LOGICAL-c312t-ada9dc60714086da90016aa0bb788e9d0587c724075a8918dd7c02288ba85c7b3</originalsourceid><addsrcrecordid>eNpF0E1LxDAQBuAgiq4fJ--Si16060zTJulRZP3ABQ-u4C1M06xW22ZNWtB_b2UX9jQz8PAyvIydIkyFLtJrH6Yop9lU5mqHTVAVmKSZwN1xhxQTIfK3A3YY4ydAqkAW--wAZSGLTMkJe5n9rIKLsfYd90vefzjeDj31ruJ9oC5-ud43FB1fPC3meMWJt75xdmgo8JbClwu87vg7xT7UllvqrAvHbG9JTXQnm3nEXu9mi9uHZP58_3h7M0-swLRPqKKishIUZqDleACgJIKyVFq7ooJcK6vSDFROukBdVcpCmmpdks6tKsURu1jnroL_HlzsTVtH65qGOueHaKTWUgjAEV6uoQ0-xuCWZhXq8ftfg2D-OzQ-GJQmM2OHoz7bxA5l66qt3ZQ2gvMNoGipWY492TpuncYcUIH4A4Y6eQ4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68863301</pqid></control><display><type>article</type><title>Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>STAIGER, Wilko I ; COY, Johannes F ; GROBHOLZ, Rainer ; HOFHEINZ, Ralf-Dieter ; LUKAN, Nadine ; POST, Stefan ; SCHWARZBACH, Matthias H ; WILLEKE, Frank</creator><creatorcontrib>STAIGER, Wilko I ; COY, Johannes F ; GROBHOLZ, Rainer ; HOFHEINZ, Ralf-Dieter ; LUKAN, Nadine ; POST, Stefan ; SCHWARZBACH, Matthias H ; WILLEKE, Frank</creatorcontrib><description>The nonoxidative pentose phosphate pathway allows glucose conversion to ribose for DNA or RNA synthesis and glucose degradation to lactate controlled by transketolase enzyme reactions. It has been postulated, that this pathway is of the utmost importance in tumors for the proliferation process. We detected a strong upregulation of the mutated transketolase transcript (TKTL1) in a considerable number of patients with gastric cancer (GC) or cancer of the gastroesophageal junction (GEJ). While only 10.8% of the cancer tissues revealed a significant mRNA upregulation, 36.9% of the cancer tissues demonstrated a protein overexpression. We propose that TKTL1 upregulation is a common phenomenon in GC and cancer of the GEJ leading to an enhanced, oxygen-independent glucose usage which might contribute to a more aggressive tumor growth. Since molecular targeted inhibition of transketolase enzyme reactions suppresses tumor growth and metastasis, TKTL1 could be a relevant target for anti-transketolase therapies in gastric cancer.</description><identifier>ISSN: 1021-335X</identifier><identifier>EISSN: 1791-2431</identifier><identifier>DOI: 10.3892/or.16.4.657</identifier><identifier>PMID: 16969476</identifier><language>eng</language><publisher>Athens: S.n.</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Biomarkers, Tumor ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Gene Expression Regulation, Neoplastic ; Humans ; Male ; Medical sciences ; Middle Aged ; Mutation ; Neoplasm Metastasis ; Oxygen - metabolism ; RNA, Messenger - metabolism ; Stomach Neoplasms - metabolism ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Transketolase - biosynthesis ; Transketolase - genetics ; Tumors</subject><ispartof>Oncology reports, 2006-10, Vol.16 (4), p.657-661</ispartof><rights>2006 INIST-CNRS</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18150170$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16969476$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>STAIGER, Wilko I</creatorcontrib><creatorcontrib>COY, Johannes F</creatorcontrib><creatorcontrib>GROBHOLZ, Rainer</creatorcontrib><creatorcontrib>HOFHEINZ, Ralf-Dieter</creatorcontrib><creatorcontrib>LUKAN, Nadine</creatorcontrib><creatorcontrib>POST, Stefan</creatorcontrib><creatorcontrib>SCHWARZBACH, Matthias H</creatorcontrib><creatorcontrib>WILLEKE, Frank</creatorcontrib><title>Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer</title><title>Oncology reports</title><addtitle>Oncol Rep</addtitle><description>The nonoxidative pentose phosphate pathway allows glucose conversion to ribose for DNA or RNA synthesis and glucose degradation to lactate controlled by transketolase enzyme reactions. It has been postulated, that this pathway is of the utmost importance in tumors for the proliferation process. We detected a strong upregulation of the mutated transketolase transcript (TKTL1) in a considerable number of patients with gastric cancer (GC) or cancer of the gastroesophageal junction (GEJ). While only 10.8% of the cancer tissues revealed a significant mRNA upregulation, 36.9% of the cancer tissues demonstrated a protein overexpression. We propose that TKTL1 upregulation is a common phenomenon in GC and cancer of the GEJ leading to an enhanced, oxygen-independent glucose usage which might contribute to a more aggressive tumor growth. Since molecular targeted inhibition of transketolase enzyme reactions suppresses tumor growth and metastasis, TKTL1 could be a relevant target for anti-transketolase therapies in gastric cancer.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Biomarkers, Tumor</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Neoplasm Metastasis</subject><subject>Oxygen - metabolism</subject><subject>RNA, Messenger - metabolism</subject><subject>Stomach Neoplasms - metabolism</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Transketolase - biosynthesis</subject><subject>Transketolase - genetics</subject><subject>Tumors</subject><issn>1021-335X</issn><issn>1791-2431</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0E1LxDAQBuAgiq4fJ--Si16060zTJulRZP3ABQ-u4C1M06xW22ZNWtB_b2UX9jQz8PAyvIydIkyFLtJrH6Yop9lU5mqHTVAVmKSZwN1xhxQTIfK3A3YY4ydAqkAW--wAZSGLTMkJe5n9rIKLsfYd90vefzjeDj31ruJ9oC5-ud43FB1fPC3meMWJt75xdmgo8JbClwu87vg7xT7UllvqrAvHbG9JTXQnm3nEXu9mi9uHZP58_3h7M0-swLRPqKKishIUZqDleACgJIKyVFq7ooJcK6vSDFROukBdVcpCmmpdks6tKsURu1jnroL_HlzsTVtH65qGOueHaKTWUgjAEV6uoQ0-xuCWZhXq8ftfg2D-OzQ-GJQmM2OHoz7bxA5l66qt3ZQ2gvMNoGipWY492TpuncYcUIH4A4Y6eQ4</recordid><startdate>20061001</startdate><enddate>20061001</enddate><creator>STAIGER, Wilko I</creator><creator>COY, Johannes F</creator><creator>GROBHOLZ, Rainer</creator><creator>HOFHEINZ, Ralf-Dieter</creator><creator>LUKAN, Nadine</creator><creator>POST, Stefan</creator><creator>SCHWARZBACH, Matthias H</creator><creator>WILLEKE, Frank</creator><general>S.n.</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20061001</creationdate><title>Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer</title><author>STAIGER, Wilko I ; COY, Johannes F ; GROBHOLZ, Rainer ; HOFHEINZ, Ralf-Dieter ; LUKAN, Nadine ; POST, Stefan ; SCHWARZBACH, Matthias H ; WILLEKE, Frank</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c312t-ada9dc60714086da90016aa0bb788e9d0587c724075a8918dd7c02288ba85c7b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Biomarkers, Tumor</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Neoplasm Metastasis</topic><topic>Oxygen - metabolism</topic><topic>RNA, Messenger - metabolism</topic><topic>Stomach Neoplasms - metabolism</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Transketolase - biosynthesis</topic><topic>Transketolase - genetics</topic><topic>Tumors</topic><toplevel>online_resources</toplevel><creatorcontrib>STAIGER, Wilko I</creatorcontrib><creatorcontrib>COY, Johannes F</creatorcontrib><creatorcontrib>GROBHOLZ, Rainer</creatorcontrib><creatorcontrib>HOFHEINZ, Ralf-Dieter</creatorcontrib><creatorcontrib>LUKAN, Nadine</creatorcontrib><creatorcontrib>POST, Stefan</creatorcontrib><creatorcontrib>SCHWARZBACH, Matthias H</creatorcontrib><creatorcontrib>WILLEKE, Frank</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Oncology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>STAIGER, Wilko I</au><au>COY, Johannes F</au><au>GROBHOLZ, Rainer</au><au>HOFHEINZ, Ralf-Dieter</au><au>LUKAN, Nadine</au><au>POST, Stefan</au><au>SCHWARZBACH, Matthias H</au><au>WILLEKE, Frank</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer</atitle><jtitle>Oncology reports</jtitle><addtitle>Oncol Rep</addtitle><date>2006-10-01</date><risdate>2006</risdate><volume>16</volume><issue>4</issue><spage>657</spage><epage>661</epage><pages>657-661</pages><issn>1021-335X</issn><eissn>1791-2431</eissn><abstract>The nonoxidative pentose phosphate pathway allows glucose conversion to ribose for DNA or RNA synthesis and glucose degradation to lactate controlled by transketolase enzyme reactions. It has been postulated, that this pathway is of the utmost importance in tumors for the proliferation process. We detected a strong upregulation of the mutated transketolase transcript (TKTL1) in a considerable number of patients with gastric cancer (GC) or cancer of the gastroesophageal junction (GEJ). While only 10.8% of the cancer tissues revealed a significant mRNA upregulation, 36.9% of the cancer tissues demonstrated a protein overexpression. We propose that TKTL1 upregulation is a common phenomenon in GC and cancer of the GEJ leading to an enhanced, oxygen-independent glucose usage which might contribute to a more aggressive tumor growth. Since molecular targeted inhibition of transketolase enzyme reactions suppresses tumor growth and metastasis, TKTL1 could be a relevant target for anti-transketolase therapies in gastric cancer.</abstract><cop>Athens</cop><pub>S.n.</pub><pmid>16969476</pmid><doi>10.3892/or.16.4.657</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1021-335X
ispartof Oncology reports, 2006-10, Vol.16 (4), p.657-661
issn 1021-335X
1791-2431
language eng
recordid cdi_proquest_miscellaneous_68863301
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adult
Aged
Aged, 80 and over
Biological and medical sciences
Biomarkers, Tumor
Female
Gastroenterology. Liver. Pancreas. Abdomen
Gene Expression Regulation, Neoplastic
Humans
Male
Medical sciences
Middle Aged
Mutation
Neoplasm Metastasis
Oxygen - metabolism
RNA, Messenger - metabolism
Stomach Neoplasms - metabolism
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Transketolase - biosynthesis
Transketolase - genetics
Tumors
title Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T08%3A34%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20the%20mutated%20transketolase%20TKTL1,%20a%20molecular%20marker%20in%20gastric%20cancer&rft.jtitle=Oncology%20reports&rft.au=STAIGER,%20Wilko%20I&rft.date=2006-10-01&rft.volume=16&rft.issue=4&rft.spage=657&rft.epage=661&rft.pages=657-661&rft.issn=1021-335X&rft.eissn=1791-2431&rft_id=info:doi/10.3892/or.16.4.657&rft_dat=%3Cproquest_cross%3E68863301%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68863301&rft_id=info:pmid/16969476&rfr_iscdi=true